IMPERIAL COLLEGE LONDON DIABETES CENTRE DESIGNATED A CENTRE OF EXCELLENCE BY THE INTERNATIONAL DIABETES FEDERATION

13

Mubadala Health partner becomes one of the few institutions within the MENA region to meet the stringent standards required for this certification

Dr Alya Al Mazrouei, Acting Executive Director of Mubadala Health’s ICLDC

Abu Dhabi, United Arab Emirates: Mubadala Health’s Imperial College London Diabetes Centre (ICLDC) has been approved as a Centre of Excellence by the International Diabetes Federation (IDF). The Centre joins a prestigious global network of diabetes institutions recognised for their efforts to initiate, coordinate, facilitate and conduct holistic diabetes services and multidisciplinary education in diabetes and related chronic diseases.

Dr Alya Al Mazrouei, Acting Executive Director of Mubadala Health’s ICLDC, said: “It is an honour to be designated a Centre of Excellence by such a highly respected organisation as the International Diabetes Federation. We are particularly looking forward to providing a UAE and regional perspective on diabetes care and research, as well as playing our part in informing best-practice policies.”

The IDF is an umbrella organisation of over 240 national diabetes associations in 168 countries and territories. It is responsible for many initiatives that inform and guide the treatment of diabetes globally, from its research initiatives and publication of the IDF Diabetes Atlas containing invaluable statistics and demographics on diabetes prevalence, to educational programmes and advocacy activities on behalf of people with diabetes.

ICLDC is one of only six institutions (clinical/research institutes) in the MENA region to be named an IDF Centre of Excellence.

To be considered for designation as an IDF Centre of Excellence, healthcare providers need to meet numerous standards. These include being operational for at least 15 years; possessing state-of-the-art infrastructure providing diabetes care services and education; contributing to diabetes research; and having a multidisciplinary team of health professionals actively involved in diabetes care, prevention and advocacy.

Dr Al Mazrouei adds: “The opportunities for knowledge sharing arising from our collaboration with the IDF and fellow Centres of Excellence globally will allow ICLDC to enhance our work in our four key focus areas, namely diabetes treatment, research, training, and public health awareness.”

The President-Elect of the International Diabetes Federation, Professor Akhtar Hussain, emphasises: “IDF is committed to supporting the development of health professionals so they are equipped to deliver high quality care to people with diabetes and those at risk of developing the condition. Our Centres of Excellence programme aims to build an international collaborative network of clinical and research institutes to support IDF’s mission of promoting diabetes care and prevention worldwide. We are delighted to welcome Mubadala Health’s Imperial College London Diabetes Centre and look forward to further expansion of our network in the MENA region, one of the hardest hit by the impact of diabetes.”  

About Mubadala Health:

Mubadala Health is the integrated healthcare network of Mubadala Investment Company. Established 2021, Mubadala Health operates, manages, and develops a portfolio of healthcare assets including: Abu Dhabi Telemedicine Centre (ADTC), Amana Healthcare, Capital Health Screening Centre (CHSC), Healthpoint, Imperial College London Diabetes Centre (ICLDC), and National Reference Laboratory (NRL). In addition, Cleveland Clinic Abu Dhabi is an integral part of Mubadala Health. With a vision to transform the regional healthcare landscape, Mubadala Health sets a new benchmark for the UAE and regional healthcare industry through its state-of-the-art facilities and world-class caregivers who strive to put patients first across its continuum of care. Innovation, research, and education are the foundational pillars of Mubadala Health, supporting the further development of a sustainable healthcare sector in line with the vision of Abu Dhabi and the region.

Mubadala Health is on Twitter, Instagram, Facebook and LinkedIn with the handle: @mubadalahealth.

About Imperial College London Diabetes Centre:

Imperial College London Diabetes Centre (ICLDC), a Mubadala Health partner, is a state-of-the-art outpatient facility that specialises in diabetes treatment, research, training and public health awareness. In just over a decade, the Centre has gained international renown for its holistic approach to the treatment of diabetes and related complications that enables patients to receive the full spectrum of care they need in one place.

With more than 80 diabetes professionals and endocrinologists under one roof, ICLDC offers best-in-class medical attention from first diagnosis to disease management across 11 specialist practice areas including adult and paediatric endocrinology, treatment of metabolic and electrolyte disorders, pre- and post-bariatric surgery care, heart disease prevention, nutritional advice, diabetes education services, ophthalmology, nephrology and podiatry.

ICLDC was established in 2006 in Abu Dhabi by Mubadala in partnership with the UK’s Imperial College London to address the growing demand for diabetes care in the UAE. The centre now operates three branches across Abu Dhabi and Al Ain, touching the lives of more than one million people through patient-centric programmes and public health initiatives. In 2007, ICLDC launched Diabetes. Knowledge. Action, now the longest running public health awareness campaign in the country. The initiative promotes an active lifestyle through an ongoing calendar of events for the whole community – Major activations include an annual walkathon that coincides with the World Diabetes Day in November.

ICLDC holds the Joint Commission International (JCI) Clinical Care Program Certification in Outpatient Diabetes Management and JCI Accreditation for Ambulatory Care.